MRX001 is a blister based multidose dry powder inhaler (DPI). MRX001 is based on the open-click-inhale-close principle and can be used as a drug delivery device for cannabinoids.
It is the device of choice for daily use of CBD/THC therapies, where the user may not wish nor be able to handle the product dose as in a capsule inhaler. It is also a device that offers a child resistant primary packaging more robust than a capsule.
It can be supplied as a pre-assembled device ready to be completed with a blister strip manufactured at the client’s facilities in the country of their choice.
MRX001 is available with all the necessary documentation for regulated markets such as EU, US and Japan as well as emerging markets.
MRX001 uses Merxin’s proprietary designs and does not knowingly infringe any IP.